Rare missense pathogenic mutations in the leucine-rich repeat kinase 2 (LRRK2) gene that cause Parkinson’s disease (PD) upregulate LRRK2 kinase activity [1, 2]. This evidence concerns the gene LRRK2 and Parkinson disease.